neodymium has been researched along with Ocular Hypertension in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 3 (50.00) | 2.80 |
Authors | Studies |
---|---|
Çakmak, K; Erbil, H; Korkmaz, Ş; Mesci, C | 1 |
Brézin, AP; Bugnard, F; Dot, C; Goguillot, M; Labbé, A; Lignereux, F; Rozot, P; Schweitzer, C | 1 |
Gurnani, B; Kaur, K | 1 |
Artunay, O; Bahcecioglu, H; Rasier, R; Sengul, A; Unal, M; Yuzbasioglu, E | 1 |
Blumenthal, M; Naveh, N; Zborowsky-Gutman, L | 1 |
de Jong, PT; Leys, M; Pameijer, JH | 1 |
2 trial(s) available for neodymium and Ocular Hypertension
Article | Year |
---|---|
Comparing the effects and safety of dorzolamide hydrochloride + timolol maleate versus brimonidine after neodymium-doped yttrium aluminium garnet laser capsulotomy posterior capsule opacification.
Topics: Antihypertensive Agents; Brimonidine Tartrate; Capsule Opacification; Glaucoma; Humans; Intraocular Pressure; Lasers, Solid-State; Neodymium; Ocular Hypertension; Ophthalmic Solutions; Sulfonamides; Thiophenes; Timolol; Yttrium | 2022 |
Bimatoprost 0.03% versus brimonidine 0.2% in the prevention of intraocular pressure spike following neodymium:yttrium–aluminum–garnet laser posterior capsulotomy.
Topics: Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Brimonidine Tartrate; Capsule Opacification; Cataract; Cloprostenol; Female; Glaucoma; Humans; Intraocular Pressure; Laser Therapy; Lasers, Solid-State; Male; Middle Aged; Neodymium; Ocular Hypertension; Ophthalmic Solutions; Posterior Capsule of the Lens; Quinoxalines; Tonometry, Ocular | 2010 |
4 other study(ies) available for neodymium and Ocular Hypertension
Article | Year |
---|---|
Incidence of Retinal Detachment, Macular Edema, and Ocular Hypertension after Neodymium:Yttrium-Aluminum-Garnet Capsulotomy: A Population-Based Nationwide Study-The French YAG 2 Study.
Topics: Adult; Aged; Aged, 80 and over; Capsule Opacification; Cataract Extraction; Humans; Incidence; Laser Therapy; Lens Capsule, Crystalline; Macular Edema; Middle Aged; Neodymium; Ocular Hypertension; Postoperative Complications; Retinal Detachment | 2023 |
Re: Dot et al.: Incidence of retinal detachment, macular edema, and ocular hypertension after neodymium:yttrium-aluminum-garnet capsulotomy: a population-based nationwide study-The French YAG 2 Study (Ophthalmology. 2022;130:478-487).
Topics: Glaucoma; Humans; Incidence; Macular Edema; Neodymium; Ocular Hypertension; Retinal Detachment | 2023 |
Neodymium-YAG laser iridotomy in angle closure glaucoma: preliminary study.
Topics: Aged; Edema; Eye Hemorrhage; Female; Glaucoma, Open-Angle; Humans; Laser Therapy; Male; Middle Aged; Neodymium; Ocular Hypertension; Postoperative Complications; Prospective Studies | 1987 |
Intra ocular pressure drop after Q switched neodymium YAG laser posterior capsulotomy.
Topics: Humans; Laser Therapy; Lens Capsule, Crystalline; Lens, Crystalline; Neodymium; Ocular Hypertension; Postoperative Complications; Yttrium | 1986 |